These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 28114283)

  • 21. Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.
    Burkhalter RJ; Westfall SD; Liu Y; Stack MS
    J Biol Chem; 2015 Sep; 290(36):22143-54. PubMed ID: 26175151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway.
    Jin Y; Feng SJ; Qiu S; Shao N; Zheng JH
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3176-3184. PubMed ID: 28770968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway.
    Yoshioka S; King ML; Ran S; Okuda H; MacLean JA; McAsey ME; Sugino N; Brard L; Watabe K; Hayashi K
    Mol Cancer Res; 2012 Mar; 10(3):469-82. PubMed ID: 22232518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome.
    Leng R; Liao G; Wang H; Kuang J; Tang L
    Med Oncol; 2015 Feb; 32(2):329. PubMed ID: 25585684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer.
    Zhang Y; Zhao FJ; Chen LL; Wang LQ; Nephew KP; Wu YL; Zhang S
    Oncotarget; 2014 Dec; 5(23):12291-303. PubMed ID: 25460499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue factor-factor VIIa complex induces epithelial ovarian cancer cell invasion and metastasis through a monocytes-dependent mechanism.
    Ma Z; Zhang T; Wang R; Cheng Z; Xu H; Li W; Wang Y; Wang X
    Int J Gynecol Cancer; 2011 May; 21(4):616-24. PubMed ID: 21543928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
    Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
    Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness.
    Cai J; Tang H; Xu L; Wang X; Yang C; Ruan S; Guo J; Hu S; Wang Z
    Carcinogenesis; 2012 Jan; 33(1):20-9. PubMed ID: 22021907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
    Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COL11A1 activates cancer-associated fibroblasts by modulating TGF-β3 through the NF-κB/IGFBP2 axis in ovarian cancer cells.
    Wu YH; Huang YF; Chang TH; Chen CC; Wu PY; Huang SC; Chou CY
    Oncogene; 2021 Jul; 40(26):4503-4519. PubMed ID: 34117361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of IGF1 by tumor-associated macrophages promotes the proliferation and migration of epithelial ovarian cancer cells.
    Liu L; Wang X; Li X; Wu X; Tang M; Wang X
    Oncol Rep; 2018 Feb; 39(2):818-826. PubMed ID: 29251331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y; Dun Y; Zhou S; Huang XH
    Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer.
    Yue H; Li W; Chen R; Wang J; Lu X; Li J
    Gynecol Oncol; 2021 Feb; 160(2):530-538. PubMed ID: 33317907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crk-like adapter protein regulates CCL19/CCR7-mediated epithelial-to-mesenchymal transition via ERK signaling pathway in epithelial ovarian carcinomas.
    Cheng S; Guo J; Yang Q; Yang X
    Med Oncol; 2015 Mar; 32(3):47. PubMed ID: 25636509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment.
    Jiang H; Lin X; Liu Y; Gong W; Ma X; Yu Y; Xie Y; Sun X; Feng Y; Janzen V; Chen T
    Mol Med; 2012 Oct; 18(1):1197-208. PubMed ID: 22801793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The metastatic phenotype shift toward myofibroblast of adipose-derived mesenchymal stem cells promotes ovarian cancer progression.
    Tang H; Chu Y; Huang Z; Cai J; Wang Z
    Carcinogenesis; 2020 Apr; 41(2):182-193. PubMed ID: 31046126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of integrin β1 mediates the increased malignant potential of ovarian cancer cells exerted by inflammatory cytokines.
    Yang Z; Zhou X; Liu Y; Gong C; Wei X; Zhang T; Ma D; Gao Q
    Anticancer Agents Med Chem; 2014; 14(7):955-62. PubMed ID: 24931361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of SLC7A1 in high-grade serous ovarian cancer promotes tumor progression and is involved in MAPK/ERK pathway and EMT.
    You S; Han X; Xu Y; Sui L; Song K; Yao Q
    Cancer Med; 2024 May; 13(10):e7217. PubMed ID: 38752472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer.
    Qin S; Li Y; Cao X; Du J; Huang X
    Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 27884977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.
    Llauradó M; Abal M; Castellví J; Cabrera S; Gil-Moreno A; Pérez-Benavente A; Colás E; Doll A; Dolcet X; Matias-Guiu X; Vazquez-Levin M; Reventós J; Ruiz A
    Int J Cancer; 2012 Apr; 130(7):1532-43. PubMed ID: 21520040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.